Navigating the Clinical & Regulatory Pathway to Approval in Rare Kidney Disease
- Demonstrating efficacy across multiple endpoints to support regulatory decisionmaking in rare kidney disease
- Designing clinical programs that balance feasibility with the need for robust and clinically meaningful data
- Overcoming challenges associated with small, heterogeneous patient populations in late-stage development